Houlihan Lokey, Inc. (NYSE:HLI - Get Free Report) has been given an average rating of "Hold" by the six brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $157.00.
Several equities analysts recently weighed in on HLI shares. Wells Fargo & Company started coverage on Houlihan Lokey in a research report on Thursday, September 12th. They set an "underweight" rating and a $149.00 target price on the stock. Morgan Stanley increased their target price on Houlihan Lokey from $146.00 to $163.00 and gave the stock an "equal weight" rating in a research report on Monday, September 23rd. Keefe, Bruyette & Woods reiterated a "market perform" rating and set a $154.00 target price (up from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. JPMorgan Chase & Co. reduced their target price on Houlihan Lokey from $132.00 to $129.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 31st. Finally, UBS Group increased their target price on Houlihan Lokey from $170.00 to $190.00 and gave the stock a "buy" rating in a research report on Tuesday, October 8th.
Check Out Our Latest Analysis on HLI
In other news, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $168.08, for a total value of $33,616.00. Following the completion of the sale, the director now owns 6,601 shares in the company, valued at approximately $1,109,496.08. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Houlihan Lokey news, Chairman Scott L. Beiser sold 8,317 shares of the firm's stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $151.89, for a total transaction of $1,263,269.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gillian Beth Zucker sold 200 shares of the firm's stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $168.08, for a total value of $33,616.00. Following the sale, the director now owns 6,601 shares of the company's stock, valued at approximately $1,109,496.08. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,917 shares of company stock worth $1,513,129. 23.68% of the stock is currently owned by corporate insiders.
Hedge funds have recently bought and sold shares of the business. Opal Wealth Advisors LLC acquired a new stake in Houlihan Lokey during the 2nd quarter valued at approximately $26,000. Crewe Advisors LLC grew its stake in Houlihan Lokey by 264.5% during the 2nd quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 164 shares in the last quarter. Wolff Wiese Magana LLC acquired a new stake in Houlihan Lokey during the 3rd quarter valued at approximately $38,000. Ashton Thomas Private Wealth LLC acquired a new stake in Houlihan Lokey during the 2nd quarter valued at approximately $38,000. Finally, Quest Partners LLC bought a new position in Houlihan Lokey during the 3rd quarter worth approximately $92,000. Institutional investors and hedge funds own 78.07% of the company's stock.
Shares of NYSE:HLI opened at $183.60 on Friday. Houlihan Lokey has a 52-week low of $100.92 and a 52-week high of $189.17. The stock's fifty day simple moving average is $162.90 and its 200-day simple moving average is $147.08. The company has a market capitalization of $12.77 billion, a P/E ratio of 37.55 and a beta of 0.65.
Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.15. Houlihan Lokey had a return on equity of 19.29% and a net margin of 15.77%. The business had revenue of $574.96 million for the quarter, compared to the consensus estimate of $537.93 million. During the same period in the prior year, the business earned $1.11 earnings per share. The business's revenue was up 23.1% on a year-over-year basis. On average, sell-side analysts anticipate that Houlihan Lokey will post 5.79 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Sunday, December 15th. Stockholders of record on Monday, December 2nd will be paid a $0.57 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.24%. Houlihan Lokey's dividend payout ratio (DPR) is currently 46.63%.
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.